openPR Logo
Press release

Geriatric Medicines Market to Witness a Pronounce Growth During 2018 to 2026.

10-27-2018 09:32 AM CET | Health & Medicine

Press release from: Polaris Market Research & Consulting

Geriatric Medicines Market

Geriatric Medicines Market

Geriatric Medicines Market [By Therapeutic Category (Analgesics, Antihypertensive, Statins, Antidiabetics, Proton Pump Inhibitor, Anticoagulant, Antipsychotic, and Antidepressant); By Therapeutic Conditions (Cardiovascular, Arthritis, Neurological, Cancer, Osteoporosis, and Respiratory); and by Regions (North America - U.S., Canada; Europe - Germany, UK, France, Italy, Russia; Asia-Pacific - China, India, Japan, Australia; Latin America - Brazil, Mexico; Middle East & Africa)]: Market size & Forecast, 2018 – 2026

The Global Geriatric Medicines Market Size is anticipated to reach over USD 1,157.34 billion by 2026 according to a new research published by Polaris Market Research.

Geriatric medicines, also called geriatrics is a division of medicines associated with preventive, clinical, remedial, and social aspects of disease generally amongst people that are aged over 65 years or more. In response to the needs of an aging population, demand for geriatric medicines and appropriate cure has developed rapidly during last decades. The proper medical care for the geriatric patients across the range of ill health conditions includes co-morbid complications such as syncope, cerebral aging, and falls among others.

Request For Sample Copy of This Report @ http://bit.ly/2PTKwwe

The global geriatric medicines market is majorly driven by the factor including a rise in geriatric populations. According to the Eurostat, the number of people aged 65 years and above is expected reach 141 million by 2050 globally. In addition, the high market growth is expected on account of the increasing occurrence of numerous target disorders in the geriatric population, the demographic modification, the rising trend in lifestyle-associated risk aspects, and the considerably developed access to economic medicine across the developing and emerging regions. Continuous R&D activities commenced by key players and pharmaceutical companies to provide to the patient demand is expected to gain the significant outcomes during the forecast period. Increasing occurrence of chronic ailments, refining healthcare organization in emerging economies, increasing acceptance of medical tourism, government initiatives as well as support to provide timely care, and increasing number of specialty clinics are some of the other factors driving of the geriatric medicines market. However, difficulties associated with drug compatibility, lack of patient involvement in clinical trials, and side effects associated with the medications are the factors hampering the market growth.

The global Geriatric Medicines Market is segmented on the basis of therapeutic category, therapeutic condition, and geography.

Make an inquiry for purchasing this report @ http://bit.ly/2Q6fuBe

On the basis of therapeutic category, the global geriatric medicines market is segmented into Analgesics, Antihypertensive, Statins, Antidiabetics, Proton Pump Inhibitor, Anticoagulant, Antipsychotic, and Antidepressant. Pain as an indication is associated with old age and the middle age population unveils the high occurrence rate of pain related syndromes. Based on current trends and the demand for proper therapy, the market is anticipated to witness high growth for therapeutic conditions during the forecast period. On the basis of therapeutic conditions, the global geriatric medicines market is segmented into Cardiovascular, Arthritis, Neurological, Cancer, Osteoporosis, and Respiratory. In 2017, the cardiovascular disease is estimated to be the dominating segment primarily due to the high proliferation of several cardiac disorders such as coronary artery disease, stroke, and hypertension.

North America is estimated to dominate the global Geriatric Medicines Market. The existence of developed healthcare facilities, favorable reimbursement policies, and the easy availability of important as well as life-saving medicine has significantly enhanced the average life expectancy rates in North America. Moreover, the number of people that are over 65 to 70 years suffering several target ailments is increasing continually which is further anticipated to boost the geriatric medicines market during the forecast period.

Some major key players in global Geriatric Medicines Market include GlaxoSmithKline Plc, BoehringerIngelheim GmbH, Novartis AG, Bristol-Myers Squibb Company, Pfizer, Inc., Eli Lilly and Company, Abbott Laboratories Inc., AstraZeneca plc, Merck & Company Inc., and Sanofi S.A. among others.

Browse Complete Details @ http://bit.ly/2Q4ok2M

About us Polaris Market Research
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments and latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced and extremely qualified team of experts comprising SMEs, analysts and consultants, we at Polaris endeavor to deliver value-added business solutions to our customers.

Contact us-
Mr. Neel
Corporate Sales, USA
Polaris Market Research
Phone: 1-646-568-9980
Email: sales@polarismarketresearch.com
Web: www.polarismarketresearch.com
Follow us- LinkedIn | Twitter | Facebook

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Geriatric Medicines Market to Witness a Pronounce Growth During 2018 to 2026. here

News-ID: 1333426 • Views:

More Releases from Polaris Market Research & Consulting

Data as a Service Market on Track to Hit USD 125.40 Billion By 2032, Propelled by an Impressive CAGR of 30.00%
Data as a Service Market on Track to Hit USD 125.40 Billion By 2032, Propelled b …
According to a new market research report published by Polaris Market Research, the global Data as a Service Market is expected to grow at a CAGR of 30.00% from 2024 to 2032. The potential to offer firms worth of their data benefits and permit them to provide their substantial data to outermost parties effortlessly are anticipated to drive market expansion. The global market was valued at USD 11.87 billion in
Maritime Satellite Communication Market Trends Analysis & Growth Factor is Expected to Reach USD 8.35 Billion By 2032
Maritime Satellite Communication Market Trends Analysis & Growth Factor is Expec …
According to a new market research report published by Polaris Market Research, the global Maritime Satellite Communication Market was valued at USD 4.18 billion in 2023 to USD 8.35 billion by 2032, disclosing a CAGR of 8.20% during the forecast period of 2024-2032. Growing demand for voice communication solicitation in several sectors, including passenger ships, fishing, and marine shipping, is anticipated to drive market expansion. 𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 𝐨𝐟 𝐭𝐡𝐞 𝐑𝐞𝐩𝐨𝐫𝐭:
Form Fill and Sealing (FFS) Equipment Market With Exhibiting a CAGR of 7.20% to Reach USD 15,607.07 Million by 2032
Form Fill and Sealing (FFS) Equipment Market With Exhibiting a CAGR of 7.20% to …
𝐓𝐡𝐞 𝐫𝐞𝐜𝐞𝐧𝐭𝐥𝐲 𝐩𝐮𝐛𝐥𝐢𝐬𝐡𝐞𝐝 𝐅𝐨𝐫𝐦 𝐅𝐢𝐥𝐥 𝐚𝐧𝐝 𝐒𝐞𝐚𝐥𝐢𝐧𝐠 (𝐅𝐅𝐒) 𝐄𝐪𝐮𝐢𝐩𝐦𝐞𝐧𝐭 𝐌𝐚𝐫𝐤𝐞𝐭 𝐬𝐭𝐮𝐝𝐲 𝐫𝐞𝐩𝐨𝐫𝐭 𝐛𝐲 𝐏𝐨𝐥𝐚𝐫𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐫𝐞𝐯𝐞𝐚𝐥𝐬 𝐭𝐡𝐚𝐭 𝐭𝐡𝐞 𝐠𝐥𝐨𝐛𝐚𝐥 𝐦𝐚𝐫𝐤𝐞𝐭 𝐰𝐚𝐬 𝐔𝐒𝐃 8361.79 𝐦𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 2023, 𝐰𝐢𝐭𝐡 𝐚 𝐂𝐀𝐆𝐑 𝐨𝐟 7.20% 𝐩𝐫𝐨𝐣𝐞𝐜𝐭𝐞𝐝 𝐟𝐫𝐨𝐦 2024 𝐭𝐨 2032. 𝐓𝐡𝐞 𝐠𝐥𝐨𝐛𝐚𝐥 𝐦𝐚𝐫𝐤𝐞𝐭 𝐢𝐬 𝐞𝐱𝐩𝐞𝐜𝐭𝐞𝐝 𝐭𝐨 𝐨𝐟𝐟𝐞𝐫 𝐚𝐧 𝐚𝐛𝐬𝐨𝐥𝐮𝐭𝐞 𝐨𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐲 𝐨𝐟 𝐔𝐒𝐃 15,607.07 𝐦𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 2032. The growing acquisition of many kinds of inventive technologies involving motion regulation or human-machine boundaries and the escalated
Peppermint Oil Market Envisioned to Reach US$ 673.25 Million by 2032, Growing at 6.70% CAGR During 2024-2032
Peppermint Oil Market Envisioned to Reach US$ 673.25 Million by 2032, Growing at …
The Global Peppermint Oil Market reached USD 377.48 million in 2023 and is expected to reach USD 673.25 million by 2032, growing at a CAGR of 6.70% from 2024 to 2032. 𝐆𝐚𝐢𝐧 𝐈𝐦𝐦𝐞𝐝𝐢𝐚𝐭𝐞 𝐀𝐜𝐜𝐞𝐬𝐬 𝐭𝐨 𝐎𝐮𝐫 𝐄𝐱𝐜𝐥𝐮𝐬𝐢𝐯𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭: https://www.polarismarketresearch.com/industry-analysis/peppermint-oil-market/request-for-sample The peppermint plant, which grows well in North America and Europe, is the source of peppermint oil. Menthol is a chemical found in peppermint. Menthol is attributed to many of the

All 5 Releases


More Releases for Geriatric

Soaring Geriatric Demographic & Sophisticated Technology Buttress Geriatric Medi …
Governments’ relentless pitch for all-round assistance for geriatric people along with technological advancements aimed at ameliorating medical assistance has underpinned the geriatric medicines market. One of the insurance programs in the United States named as the Federal Long Term Care Insurance Program has aptly incorporated near-to-full medical cost of the Americans. Factors such as longer life-expectancy, aging demographic, swelled awareness and adoption of sophisticated therapeutics are prophesized to propel the
Cataract Market Geriatric & Future Scenario 2025
Global Cataract Market: Snapshot The incrementing demand in the global cataract market is a reflection of growing geriatric population, as people aged over 60 years frequently develop conditions wherein eyes have reduced elasticity and in turn affects the normal functioning. The market for cataract is also expected to gain from awareness programs such as VISION 2020, launched by the WHO and the International Agency for the Prevention of Blindness. Request Sample Copy
Global Geriatric Drugs and Disease Management Market: High Incidence of Chronic …
Researchmoz added Most up-to-date research on "Global Geriatric Drugs and Disease Management Market: High Incidence of Chronic Ailments among Geriatric Population Crea" to its huge collection of research reports. Geriatric medicine refers to a branch of medicine dealing with the diagnosis, treatment and prevention of diseases in the elderly population. Increasing demand for geriatric care medication and services is attributed to increasing needs of the elderly population. The geriatric population suffers
Geriatric Medicines Market Analysis & Trends 2023
The global market for geriatric medicines stood at US$ 504.7 bn in 2014 and is projected to expand at a CAGR of 7.3 % during 2015–2023. Rising at this pace, the opportunities in the market is anticipated to reach US$ 948.0 bn by the end of 2023. Governments’ Push for Quality Geriatric Care Bodes Well for Market The global geriatric medicines market is primarily driven the general rise in the elderly populations
Consistent Rise in Geriatric Population is Expected to Stimulate the Growth of G …
Geriatric population is more susceptible to chronic diseases such as heart problems, joint disorders and others. Therefore, this population group needs regular use of the medicines to prevent the disease conditions. The use of complementary and alternative medicines is increasing among the geriatric population globally due to the fact that CAMs decreases the risk of adverse reactions and drug interactions. Complementary and alternative medicines include products such as dietary medicine
Consistent Rise in Geriatric Population is Expected to Stimulate Geriatric Compl …
Geriatric Complementary and Alternative Medicines (CAM) Market: Overview Geriatric population is more susceptible to chronic diseases such as heart problems, joint disorders and others. Therefore, this population group needs regular use of the medicines to prevent the disease conditions. The use of complementary and alternative medicines is increasing among the geriatric population globally due to the fact that CAMs decreases the risk of adverse reactions and drug interactions. Browse to unlock